|
|
||||||||
The Journal of Immunology, Vol 144, Issue 2 562-569, Copyright © 1990 by American Association of Immunologists
ARTICLES |
JB Splawski, LM McAnally and PE Lipsky
Department of Pediatrics, Harold C Simmons Arthritis Research Center, Dallas, Texas.
The effect of rIL-6 on the growth and differentiation of highly purified human peripheral blood B cells was examined. IL-6 alone induced minimal incorporation of [3H]thymidine by unstimulated or Staphylococcus aureus (SA)-stimulated B cells and did not augment proliferation induced by SA and IL-2. Similarly, IL-6 alone did not support the generation of Ig-secreting cells (ISC) or induce the secretion of Ig by unstimulated or SA-stimulated B cells. However, IL-6 did augment the generation of ISC and the secretion of all isotypes of Ig induced by SA and IL-2. Maximal enhancement of B cell responsiveness by IL-6 required its presence from the initiation of culture. Delaying the addition of IL-6 to B cells stimulated with SA and IL-2 beyond 24 h diminished its effect on ISC generation. However, increased Ig production but not ISC generation was observed when IL-6 was added to B cells that had been preactivated for 48 h with SA and IL-2. This effect was most marked when the activated B cells were also stimulated with IL- 2. IL-6 in combination with other cytokines such as IL-1 and IL-4 did not induce the secretion of Ig or generation of ISC in the absence of IL-2. Moreover, antibody to IL-6 did not inhibit the effect of IL-2 on the growth and differentiation of B cells stimulated with SA, but did inhibit the IL-6-induced augmentation of Ig secretion by B cells stimulated with SA and IL-2. IL-6 alone enhanced T cell dependent induction of B cell differentiation stimulated by PWM. Part of this enhancement was related to its capacity to increase the production of IL-2 in these cultures. These results indicate that IL-6 has several direct enhancing effects on the differentiation of B cells, all of which are at least in part dependent on the presence of IL-2. In addition, IL-6 can indirectly increase B cell differentiation by increasing IL-2 production by T cells.
This article has been cited by other articles:
![]() |
F. Rose, G. Dahlem, B. Guthmann, F. Grimminger, U. Maus, J. Hanze, N. Duemmer, U. Grandel, W. Seeger, and H. A. Ghofrani Mediator generation and signaling events in alveolar epithelial cells attacked by S. aureusalpha -toxin Am J Physiol Lung Cell Mol Physiol, February 1, 2002; 282(2): L207 - L214. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Jego, R. Bataille, and C. Pellat-Deceunynck Interleukin-6 is a growth factor for nonmalignant human plasmablasts Blood, March 15, 2001; 97(6): 1817 - 1822. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rose, S.-A. Zeller, T. Chakraborty, E. Domann, T. Machleidt, M. Kronke, W. Seeger, F. Grimminger, and U. Sibelius Human Endothelial Cell Activation and Mediator Release in Response to Listeria monocytogenes Virulence Factors Infect. Immun., February 1, 2001; 69(2): 897 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kuwana, T. A. Medsger Jr., and T. M. Wright Analysis of Soluble and Cell Surface Factors Regulating Anti-DNA Topoisomerase I Autoantibody Production Demonstrates Synergy Between Th1 and Th2 Autoreactive T Cells J. Immunol., June 15, 2000; 164(12): 6138 - 6146. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Agematsu, H. Nagumo, Y. Oguchi, T. Nakazawa, K. Fukushima, K. Yasui, S. Ito, T. Kobata, C. Morimoto, and A. Komiyama Generation of Plasma Cells From Peripheral Blood Memory B Cells: Synergistic Effect of Interleukin-10 and CD27/CD70 Interaction Blood, January 1, 1998; 91(1): 173 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cunningham-Rundles, K. Kazbay, J. Hassett, Z. Zhou, and L. Mayer Enhanced Humoral Immunity in Common Variable Immunodeficiency after Long-Term Treatment with Polyethylene Glycol-Conjugated Interleukin-2 N. Engl. J. Med., October 6, 1994; 331(14): 918 - 921. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |